Spyridon Papapetropoulos, Director at Adamas Pharmaceuticals Inc (ADMS), bought 5,975 shares at $5.06 ($30K) on 2021-03-11, disclosed to the SEC on 2021-03-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.